ARTG Entry

XELABINE

ARTG entry for XELABINE (capecitabine), ARTG 213045 — Product Information, dosage form, registration history. Compiled by arcimedes.

• Sponsor: Viatris
• Active ingredient: capecitabine
• Therapeutic area: Oncology

TGA Public Summary — ARTG 213045